TipRanks
Provectus Pharmaceuticals (PVCT)
OTHER OTC:PVCT
US Market
PVCT
Provectus Pharmaceuticals
RESEARCH TOOLSreports

Provectus Pharmaceuticals (PVCT) Income Statement

81 Followers

Provectus Pharmaceuticals Income Statement

Last quarter (Q2 2026), Provectus Pharmaceuticals's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q2, Provectus Pharmaceuticals's net income was $-982.57K. See Provectus Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 336.11K$ 617.14K$ 557.71K$ 989.04K$ 0.00
Gross Profit
$ 334.25K$ 609.98K$ -1.14M$ 925.26K$ -94.12K
Operating Expenses
$ 5.18M$ 4.56M$ 3.47M$ 3.39M$ 4.64M
Depreciation and Amortization
$ 1.86K$ 7.16K$ 8.92K$ 63.78K$ 94.12K
EBITDA
$ -4.84M$ -4.53M$ -2.89M$ -3.36M$ -4.62M
Operating Income
$ -4.84M$ -3.95M$ -2.90M$ -3.43M$ -4.67M
Other Income/Expenses
$ -660.86K$ -816.63K$ -201.00K$ -127.00K$ -867.00K
Pretax Income
$ -5.51M$ -4.77M$ -3.12M$ -3.56M$ -5.54M
Net Income
$ -5.43M$ -4.73M$ -3.10M$ -3.55M$ -5.54M
Per Share Metrics
Basic EPS
$ -0.01$ -0.01$ >-0.01$ >-0.01$ -0.02
Diluted EPS
$ -0.01$ -0.01$ >-0.01$ >-0.01$ -0.02
Weighted Average Shares Outstanding
 420.28M 419.81M 419.51M 419.47M 408.22M
Weighted Average Shares Outstanding (Diluted)
 420.28M 419.81M 419.51M 419.47M 408.22M
Currency in USD

Provectus Pharmaceuticals Earnings and Revenue History